Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Firebrick Pharma Limited ( (AU:FRE) ) has issued an announcement.
Firebrick Pharma has secured Canadian acceptance of a key patent covering its Nasodine Nasal Spray and other intranasal povidone-iodine products for reducing SARS-CoV-2 viral load in the nose and for pre-exposure prophylaxis against COVID-19. This is the company’s second Nasodine patent in Canada and extends protection for its COVID-related applications to 2040, complementing similar patent coverage already obtained in the United States, Europe, Australia and multiple other countries, and strengthening Firebrick’s global intellectual property position around its Nasodine platform.
The broadened patent estate supports Firebrick’s strategy to commercialise Nasodine as both a treatment and preventative option in respiratory viral infections, potentially enhancing the product’s competitiveness and value as it rolls out into more markets. By reinforcing its IP protection in another major jurisdiction, the company improves its ability to defend market share, attract partners and investors, and leverage its growing Nasodine product range as it targets expansion into up to 10 international markets over the coming years.
More about Firebrick Pharma Limited
Firebrick Pharma Limited is an Australian pharmaceutical company focused on developing and commercialising novel formulations and uses of povidone-iodine (PVP-I). Its lead product, Nasodine Nasal Spray, has been introduced in the United States, Singapore, Fiji and the broader South Pacific, and was recently approved in Indonesia, with additional approvals being pursued in the Philippines and other markets. The company is expanding the Nasodine range, including a Throat Spray already available in Singapore and Fiji, and plans up to four Nasodine products sold across as many as 10 markets over the next three years.
Average Trading Volume: 120,559
Technical Sentiment Signal: Sell
Current Market Cap: A$14.81M
Learn more about FRE stock on TipRanks’ Stock Analysis page.